MiniMed and the U.S. Sunshine Act

The “Sunshine Act,” also known as “Open Payments,” is administered by the Centers for Medicare & Medicaid Services (CMS), a federal agency within the U.S. Department of Health and Human Services.

The Sunshine Act requires MiniMed and other life science manufacturers to report to CMS payments and other “transfers of value” provided to U.S. physicians, physician assistants, advanced practice registered nurses [certified nurse-midwives, certified registered nurse anesthetists, clinical nurse specialists, nurse practitioners], and teaching hospitals. Transfers of value include, among other things, meals or lodging costs associated with education programs and other lawful courtesies provided in the course of doing business, compensation for consulting services, royalty payments and others.

Life science manufacturers provide the applicable payments and transfers to CMS by March 31 for the preceding calendar year, and CMS is required to publish the submitted data on their public, searchable website by June 30.

For more information on MiniMed and the Sunshine Act:

The Committee will have the authority appropriate to discharge its duties and responsibilities, including retaining outside counsel, outside search firms and any other advisors as the Committee may deem appropriate in its sole discretion. The Committee will have sole authority to retain and terminate any such counsel, search firm or advisor, including sole authority to approve its fees and other retention terms.